SCI-GROUP AS
Org no 988 214 205 | Oslo, Norway | E-post: jj@sci-group.no
At Sci-Group we are developing a streamlined freezing technology that enables cryopreservation of cells with little to no addition of chemical cryoprotective agents.
With our system, cells can be frozen more efficiently, while minimizing the risk of cytotoxic effects.
Developing the future of cryopreservation
Sci-Group is a Norwegian biotech company dedicated to transforming the global cryopreservation industry. With CryoEmbla, our patented freezing system, we aim to facilitate safe and effective freezing of biological material without the use of chemical cryoprotective agents.
At the core of Sci-Group’s business is the development and commercialization of innovative, research-based solutions that address critical challenges in healthcare, biotechnology, and life sciences. By eliminating chemical cryoprotective agents and simplifying workflows, CryoEmbla opens new opportunities for patient treatments, biobanking, and advanced research, providing broader clinical and industrial use of living cells.
We work closely with leading research institutions, industry partners, and investors to accelerate the adoption of next-generation cryopreservation. Through strategic collaborations and pilot projects, Sci-Group is building the foundation for international growth and scalable impact.
Our vision is to set a new global standard for safe, efficient, and reproducible cryopreservation, unlocking value for healthcare, science, and society.